GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $209,000 | -99.1% | 5,121 | -99.0% | 0.00% | -100.0% |
| Q4 2020 | $22,724,000 | -25.0% | 524,675 | -4.5% | 0.04% | -36.5% |
| Q3 2020 | $30,301,000 | -11.4% | 549,528 | +1.4% | 0.06% | -21.2% |
| Q2 2020 | $34,197,000 | +34.7% | 541,686 | +9.0% | 0.08% | +2.6% |
| Q1 2020 | $25,383,000 | -34.9% | 496,837 | +1.4% | 0.08% | -21.2% |
| Q4 2019 | $38,965,000 | +76.3% | 490,192 | +7.6% | 0.10% | +59.7% |
| Q3 2019 | $22,105,000 | +6.0% | 455,582 | +14.9% | 0.06% | +3.3% |
| Q2 2019 | $20,863,000 | -0.2% | 396,629 | +0.4% | 0.06% | +1.7% |
| Q1 2019 | $20,906,000 | +54.9% | 394,985 | +20.2% | 0.06% | +31.1% |
| Q4 2018 | $13,493,000 | +89.2% | 328,740 | +75.2% | 0.04% | +125.0% |
| Q3 2018 | $7,133,000 | – | 187,664 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |